trial · primary record
ATRN-119
Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2031-11-30 |
| Primary endpoint | Number and grade of treatment-emergent adverse events (TEAEs) as assessed via CTCAE v6.0 (All Patients) |
| Registry ID | NCT07617363 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:57.972Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07617363
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.